Evaluation Of Laboratory Parameters İn Diabetic Patients During The Covid-19 Pandemic

Year 2025, Volume: 17 Issue: 2, 51 - 60, 26.08.2025

Rumeysa Ayça Akça , Ramazan Tetikçok

Abstract

Our study aimed to investigate the effects of the pandemic on the glycemic, metabolic and anthropometric values of patients diagnosed with diabetes mellitus. Patients diagnosed with diabetes mellitus (DM) who applied to the outpatient clinics of Tokat Gaziosmanpaşa University Hospital between April 2020 and April 2021 were included in our study. A total of 306 patients with diabetes mellitus, 220 female (71.9%) and 86 male (28.1%), who applied to the outpatient clinics of Tokat Gaziosmanpaşa University Hospital were included in the study. The mean HbA1c values of the patients decreased from 7.6±2.1% to 7.4±1.9%; the mean fasting plasma glucose (FPG) values decreased from 160.1±79.7 mg/dl to 151.2±68.6 mg/dl during the pandemic period ((p=0.004), (p=0.025)). The mean LDL values of the patients during the pandemic period decreased from 133.9±41.6 mg/dl to 126.6±40mg/dl; the mean total cholesterol value decreased from 216.6±46.2mg/dl to 209.2±46.7 mg/dl ((p<0.001), (p=0.001)). The mean BMI values of the patients during the pandemic period increased from 32.5 kg/m² to 32.7 kg/m². (p>0.05). Our study found an improvement in glycemic parameters (HbA1c and FPG) and lipid parameters (LDL and total cholesterol) and an increase in anthropometric measurements in patients diagnosed with DM during the pandemic period. Our study found an improvement in glycemic parameters (HbA1c and FPG) and lipid parameters (LDL and total cholesterol) and an increase in anthropometric measurements in patients diagnosed with DM during the pandemic period.

Keywords

Diabetes mellitus , Laboratory parameters , Pandemic

Covid-19 Pandemisinde Diyabet Hastalarında Laboratuvar Parametrelerinin Değerlendirilmesi

Abstract

Çalışmamızda pandeminin, diyabetes mellitus tanılı hastaların glisemik, metabolik ve antropometrik değerlerine olan etkisini incelemek amaçlanmıştır. Çalışmamıza Tokat Gaziosmanpaşa Üniversite Hastanesi polikliniklerine Nisan 2020 – Nisan 2021 tarihleri arasında başvurmuş diyabetes mellitus (DM) tanılı hastalar dahil edilmiştir. Çalışmaya Tokat Gaziosmanpaşa Üniversite Hastanesi polikliniklerine başvuran 220 kadın (%71,9), 86 erkek (%28,1) toplam 306 diyabetes mellitus tanılı hasta alındı. Hastaların pandemi döneminde HbA1c değerlerinin ortalaması %7,6±2,1’den %7,4±1,9’e; açlık plazma glukozu (APG) değerlerinin ortalaması ise 160,1±79,7 mg/dl’den 151,2±68,6 mg/dl’e düşmüştür ((p=0,004), (p=0,025)). Hastaların pandemi döneminde LDL değerlerinin ortalaması 133,9±41,6 mg/dl’den 126,6±40mg/dl’e; total kolesterol değer ortalaması 216,6±46,2mg/dl’den 209,2±46,7 mg/dl’e azalmıştır ((p<0,001), (p=0,001)). Hastaların pandemi döneminde ortalama VKİ değerleri 32,5 kg/m²’den 32,7 kg/m²’e artmıştır. (p>0,05). Çalışmamız pandemi döneminde DM tanılı hastalarda glisemik parametrelerde (HbA1c ve APG) ve lipid parametrelerinde (LDL ve total kolesterol) düzelme ve antropometrik ölçümlerinde ise artış saptamıştır.

Keywords

Diyabetes mellitus , Laboratuvar parametleri , Pandemi

Ethical Statement

Çalışma Tokat Gaziosmanpaşa Üniversitesi Sağlık Araştırma ve Uygulama Merkezi/Hastanesi Klinik Araştırmalar Etik Kurulu’ndan 17.02.2022 tarihli 202203 numaralı toplantıdan 22-KAEK-036 proje numarası ile onay almıştır.

References

• Referans 1. Peric S, Stulnig TM. Diabetes and Covid-19. Wiener Klinische Wochenschrift. 2020;132(13):356-61.
• Referans 2. Wu Y-C, Chen C-S, Chan Y-J. The outbreak of Covid-19: An overview. Journal of the Chinese medical association. 2020;83(3):217.
• Referans 3. TEMD D. Eğitim ve Çalışma Grubu: Diabetes Mellitus ve Komplikasyonlarının Tanı Tedavi ve İzlem Kılavuzu. TEMD. 2019;12:97-9.
• Referans 4. Lam DW, LeRoith D. The worldwide diabetes epidemic. Current Opinion in Endocrinology, Diabetes and Obesity. 2012;19(2):93-6.
• Referans 5. Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, et al. The effect of Covid-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(6):1963-6.
• Referans 6. Biamonte E, Pegoraro F, Carrone F, Facchi I, Favacchio G, Lania AG, et al. Weight change and glycemic control in type 2 diabetes patients during Covid-19 pandemic: the lockdown effect. Endocrine. 2021;72(3):604-10.
• Referans 7. Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, et al. Impact of Covid-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: a hospital-based survey from a country without lockdown. diabetes research and clinical practice. 2021;176:108840.
• Referans 8. Khare J, Jindal S. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India. Primary Care Diabetes. 2021;14 (6):1571-4.
• Referans 9. Selek A, Gezer E, Altun E, Sözen M, Topaloğlu Ö, Köksalan D, et al. The impact of Covid-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: A multi- center study from Kocaeli. Journal of Diabetes & Metabolic Disorders. 2021;20(2):1461-7.
• Referans 10. Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long- standing diabetes during Covid-19 lockdown: a prospective, observational, nested cohort study. International journal of diabetes in developing countries. 2020;40(4):476-81.
• Referans 11. Makki I, Alnoon N, Rahmani N, Almulla J, Alamiri A, Alfalasi A, et al. Impact of Covid-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai. Current Diabetes Reviews. 2022;18(8):88-92.
• Referans 12. Karatas S, Yesim T, Beysel S. Impact of lockdown Covid-19 on metabolic control in type 2 diabetes mellitus and healthy people. Primary Care Diabetes. 2021;15(3):424-7.
• Referans 13. Hansel B, Potier L, Chalopin S, Larger E, Gautier J-F, Delestre F, et al. The Covid-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2021;31(9):2605-11.
• Referans 14. Farhane H, Motrane M, Anaibar F-E, Motrane A, Abeid SN, Harich N. Covid-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population. Primary Care Diabetes. 2021;15(5):772-7.
• Referans 15. Biancalana E, Parolini F, Mengozzi A, Solini A. Short-term impact of Covid-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetologica. 2021;58(4):431-6.
• Referans 16. Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Therapy. 2020;11(6):1369-79.
• Referans 17. Ojo O, Wang X-H, Ojo OO, Orjih E, Pavithran N, Adegboye ARA, et al. The effects of Covid-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2022;19(3):1095.
• Referans 18. Green WD, Beck MA. Obesity impairs the adaptive immune response to influenza virus. Annals of the American Thoracic Society. 2017;14:406-9.
• Referans 19. Murat G, Tevfikoğlu Pehlivan L. Obezite, COVID-19 pandemisinde risk faktörü müdür? Turkiye Klinikleri Journal of Health Sciences. 2020;5.